Dr. Fangli Chen



Dr. Fangli Chen is vice chair of Proskauer’s Life Sciences Patent practice, and represents numerous leading companies in the biotech and pharmaceutical industries. She effectively identifies and transforms technological developments into valuable intellectual property assets for her clients and specializes in the strategic development of complex IP portfolios for companies that align with their business goals. In addition, she also handles post-grant proceedings including inter partes review, post-grant review, interference proceedings at the USPTO, and advises clients on opposition proceedings in Europe and other foreign jurisdictions. In addition, Dr. Chen performs due diligence investigations, and provides freedom-to-operate studies, non-infringement and invalidity analysis and opinions. She earned her Ph.D. in Biology from MIT, and her J.D. cum laude from Suffolk University Law School.